Citigroup’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
Citigroup's TDOC Position: Q3 2026 in Review
Citigroup reduced its Teladoc Health (TDOC) stake by 60% in Q3 2026, selling an estimated $403K and leaving 37,148 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #4173.
Citigroup first reported a position in TDOC in Q3 2015 and has held it in 44 quarters since. The position peaked at $115M in Q3 2021. 252 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.
- Citigroup held 37,148 shares of Teladoc Health worth $215K as of Q3 2026.
- Citigroup sold 55,114 Teladoc Health shares in Q3 2026, an estimated $403K.
- Teladoc Health made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4173 holding.
- Citigroup first reported a position in Teladoc Health in Q3 2015 and has held it in 44 quarters since.
- Citigroup's Teladoc Health position peaked at $115M in Q3 2021.
- 252 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.